Wilson Dumornay, MD
Facial Plastic Surgery · Plantation, FLNPI 1245327246
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Acelrx Pharmaceuticals, Inc. at 41.9% of the total. Reporting peaked in 2022 at $3,936 and has fallen 85.1% since, to $586 in 2025.
Across 98 payments — averaging $86.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acelrx Pharmaceuticals, Inc.$4K
- Stryker$2K
- Intuitive Surgical$828
- Acclarent, Inc$263
- Optinose US, Inc.$246
- Sanofi$221
- plus $1K from 19 others
What the payments were for
- Consulting fees$3,50041%
- Travel & lodging$1,61419%
- Food & beverage$3,40740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acelrx Pharmaceuticals, Inc. | 4 | $3,571 |
| Stryker | 15 | $2,111 |
| Intuitive Surgical | 16 | $828 |
| Acclarent, Inc | 3 | $263 |
| Optinose US, Inc. | 11 | $246 |
| Sanofi | 8 | $221 |
| GSK | 7 | $143 |
| Alk-abello, Inc | 6 | $134 |
| Olympus America Inc. | 1 | $131 |
| AstraZeneca | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Johnson & Johnson | 2 | $97 |
| Phadia US Inc. | 4 | $77 |
| W. L. Gore & Associates, Inc. | 1 | $67 |
| Aroa Biosurgery Incorporated | 1 | $65 |
| Smith+Nephew | 3 | $53 |
| Aerin Medical Inc. | 3 | $38 |
| Medtronic | 1 | $22 |
| Merz North America, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Intersect ENT, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Apyx Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,521 in reported general payments places this provider in the 85th percentile of 49 facial plastic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 15 | $59,159 |
| Ofloxacin | 49 | $3,044 |
| Azelastine Hcl | 126 | $2,247 |
| Fluocinolone Acetonide Oil | 28 | $1,668 |
| Ipratropium Bromide | 38 | $1,072 |
| Levocetirizine Dihydrochloride | 158 | $903 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $507 |
| Fluticasone Propionate | 45 | $417 |
| Pantoprazole Sodium | 60 | $344 |
| Levofloxacin | 94 | $337 |
| Methylprednisolone | 39 | $321 |
| Montelukast Sodium | 71 | $297 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 87 | $293 |
| Prednisone | 84 | $134 |
| Cephalexin | 19 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $143 | $59,15915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 49 facial plastic surgery providers in Florida.
Other facial plastic surgery in Plantation
- Curtis JohnsonPlantation$37K
- Jon RosenthalPlantation$2K
- Salvatore GrimaldiWest Palm Beach$310K
- Ryan GreeneWeston$101K
- John HolcombSarasota$23K
- Vijay SharmaJupiter$16K
- Zeeshan AzizFernandina Beach$15K
- Deidre LeakeSt Augustine$8K
- Nathan NachlasBoca Raton$5K
- Nikolaus HjelmMiami$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.